High GRB14 expression shows association with poor prognosis in gastric cancer, suggesting its role in treatment decisions.
This evidence highlights that GRB14 may serve as a potential candidate for both prognostic evaluation and therapeutic intervention in GC.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: